COVID-19 Vaccine Hesitancy Among the Adult Population in Saudi Arabia

Alrajeh, Ahmad M; Daghash, Hanan; Buanz, Shmayil F; Altharman, Hanin A; Belal, Safia

doi:10.7759/cureus.20197

Cited by 14 publications

(19 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Certain sociodemographic variables were associated with vaccine acceptance (p < 0.05), including being male (n = 15), 14 – 15-18 – 22-24 – 25-28 – 29-34 – 39-40 – 44 being younger (n = 5), 18 , 22 , 24 , 32 , 39 and being married (n = 3). 17 , 27 , 40 Other predictors of vaccine acceptance were positive behavior regarding the influenza vaccine or vaccines in general (n = 12), 14 , 15 , 19 , 20 , 22 , 23 , 26 , 29 , 33 , 37 , 39 , 42 a high risk perception of contracting COVID-19 (n = 12), 14 – 15-18 – 21-22 – 25-27 – 28-36 – 38-42 trust in the government/healthcare system (n = 7), 17–25 – 27–33 – 37–43 a history of chronic illnesses (n = 4), 28 , 29 , 36 , 39 being a healthcare worker (n = 2), 14 , 23 and being a smoker (n = 2). 21 , 39 In one study, being female was associated with better knowledge of, attitudes toward, and perception of the vaccine.…”

Section: Resultsmentioning

confidence: 99%

COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature

Alsalloum

Garwan

José

et al. 2022

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Vaccine hesitancy has a significant impact on tackling infectious diseases as it has resulted in reemergence of vaccine-preventable diseases. This review aims to provide an up-to-date evaluation of COVID-19 vaccine hesitancy among the public in the Gulf Cooperation Council countries. We searched the PubMed and SCOPUS databases for manuscripts published on vaccine hesitancy and/or acceptance among the public in GCC countries up till April 1 st , 2022. Forty-nine studies met the inclusion criteria and were reviewed. The average vaccine hesitancy rate across GCC countries was 43%. Concerns about vaccine safety (n = 32) and effectiveness (n = 26) were most frequently associated with hesitancy. Being male (n = 25) and having positive behavior regarding the influenza vaccine or vaccines in general (n = 22) were most frequently associated with acceptance. Collaborative efforts of governments, academic bodies, and the media to provide evidence of vaccines’ effectiveness throughout history and strictly manage the spread of the vaccine safety-related rumors are warranted.

show abstract

Section: Resultsmentioning

confidence: 99%

COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature

Alsalloum

Garwan

José

et al. 2022

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

“…It was revealed in a review that the inclined awareness about safe vaccines and being honest in reporting adverse effects could help in tackling the delay faced in vaccine acceptance and improving the uptake of immunization. 13 Several studies from various other areas of the world reported fewer side effects after administrating the first or second dose, such as pain at the site of injection, swelling, tenderness, redness, warmth, itch, and swollen armpit glands, headache, fever, fatigue, night sweats, chills and shivering, joint pain, muscle pain, nausea, vomiting, and loss of appetite. [14][15][16][17][18][19] Despite the reality that the clinical studies assured the vaccine was safe and effective, it had limitations, such as a few participants recruited in the clinical studies and a healthier than real-world sample.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study

Ali¹,

Almadan²,

Alghamdi³

et al. 2022

IDR

View full text Add to dashboard Cite

Background The purpose of this study was to examine the mild and moderate side‐effects experienced by the healthcare workers (HCWs) in the Eastern Province of Saudi Arabia after receiving the booster dose of the Pfizer-BioNTech/BNT162b2 COVID‐19 vaccine. Methods We directed a descriptive cross-sectional study among adults living in the Eastern Province of Saudi Arabia. A survey link was distributed through WhatsApp, SMS, or e-mail to HCWs. Participants’ general and demographic information were also collected, as well as information about any local and systemic side‐effects reported following vaccination. Results The results of this study showed that 81.84% (401/490) of the HCWs who contributed to this study reported the minimum COVID‐19 post‐vaccination side‐effect. Body pain (89%) and pain at the site of injection (88.73%) were the most frequent frequently reported side‐effects, followed by headache (28.68%), joint or bone pain (27.18%), muscle pain (26.43%), nausea or vomiting (21.2%), fever (18.95%), skin rashes (10.22%). History of chronic diseases had a 0.44‐fold increased risk of side-effects compared to no history of chronic diseases HCWs (adjusted odds ratio (aOR) = 0.44; 95% CI = 0.224, 0.880), and significant association of occupation with side-effects was also 1.61-fold increased risk compared to nonmedical ((aOR) = 1.61; 95% CI = 1.037, 2.513). Conclusion According to this study, the Pfizer-BioNTech/BNT162b2 COVID-19 vaccine was safe when given to Saudi Arabian HCWs. All reported side‐effects were mild to moderate. The outcomes indicated that most participants had body pain and pain at the site of injection and fatigue is among the least reported side-effect post-booster dose. Healthcare was highly connected with more reporting of side‐effects.

show abstract

“…Furthermore, a study conducted in various primary healthcare facilities in the capital city of Saudi Arabia demonstrated that, many people lack awareness of the influenza virus and its vaccine, hold strong misconceptions about side effects and believe it is useless [6,7]. A cross-sectional survey in Saudi Arabia reported that 82% of the respondents, who were adults, prefer to take precautions against the COVID-19 infection rather than take the vaccine [8].…”

Section: Introductionmentioning

confidence: 99%

“…Unlike in the western countries, the factors that predict caregivers' readiness to vaccinate children in the age group [5][6][7][8][9][10][11]…”

Section: Introductionmentioning

confidence: 99%

Factors predicting caregivers' readiness for vaccination of 5-11 years old children against SARS-CoV-2 - Saudi Arabia, 2022

Alrasheedi

Elmuttalut

AL-Mithn

et al. 2022

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: A significant proportion of parents are still reluctant to have their children vaccinated against COVID-19. This study aimed to determine what factors influence parents' decision to get COVID-19 vaccine for the children of age group 5-11 years. Methodology: A cross-sectional study was conducted in the region Qassim of Saudi Arabia, by using a self-administered, pre-tested questionnaire to assess the predicting factors of caregivers’ readiness to get their children vaccinated against COVID-19. Results: Two-thirds of the caregivers surveyed were unwilling to get their children vaccinated against COVID-19. The factors that influence the parents’ decision to get their young children (5-11 years old) vaccinated against COVID-19 were: having secondary school education (p = 0.019), family members infected with SARS-CoV-2 (p = 0.016), caregivers completed the three doses of vaccination (p = 0.003) and those who received additional flu vaccine (p = 0.014), and not experiencing the side effects of COVID-19 vaccine (p = 0.0001). Additionally, no history of COVID-19 vaccine adverse events in older 12-18 year old children (p = 0.011) and no chronic diseases in the 5-11 year old children (p = 0.001) were predictors. Conclusions: Caregivers' preferences about the children’s vaccination were influenced by multiple factors, including educational level, having family members infected with SARS-CoV-2, caregivers completing three doses of COVID-19 vaccine, receiving additional flu vaccine with no or mild adverse events, and history of chronic diseases in the child. Understanding these factors can help determine the likelihood of the caregivers getting their child vaccinated.

show abstract

COVID-19 Vaccine Hesitancy Among the Adult Population in Saudi Arabia

Cited by 14 publications

References 9 publications

COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature

COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literature

Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study

Factors predicting caregivers' readiness for vaccination of 5-11 years old children against SARS-CoV-2 - Saudi Arabia, 2022

Contact Info

Product

Resources

About